BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mingoti MED, Bertollo AG, Simões JLB, Francisco GR, Bagatini MD, Ignácio ZM. COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route. J Mol Neurosci 2022. [PMID: 35322375 DOI: 10.1007/s12031-022-02004-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao XP, Ye J, Feng T, Jiang FC, Zhou P, Wang F, Chen JG, Wu PF. Adaptor protein MyD88 confers the susceptibility to stress via amplifying immune danger signals. Brain Behav Immun 2023;108:204-20. [PMID: 36496170 DOI: 10.1016/j.bbi.2022.12.007] [Reference Citation Analysis]
2 Al-Kuraishy HM, Al-Buhadily AK, Al-Gareeb AI, Alorabi M, Hadi Al-Harcan NA, El-Bouseary MM, Batiha GE. Citicoline and COVID-19: vis-à-vis conjectured. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 36063198 DOI: 10.1007/s00210-022-02284-6] [Reference Citation Analysis]
3 Correia AS, Vale N. Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways. IJMS 2022;23:8493. [DOI: 10.3390/ijms23158493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 He Y, Han Y, Liao X, Zou M, Wang Y. Biology of cyclooxygenase-2: An application in depression therapeutics. Front Psychiatry 2022;13:1037588. [PMID: 36440427 DOI: 10.3389/fpsyt.2022.1037588] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]